Doceree, a network of physician-only platforms for programmatic messaging, has scooped up $35 million in a Series B round led by Creaegis. Existing investors Eight Roads Ventures, and F-Prime Capital also participated in the round.
Previously, it raised $11 million in its Series A round in April last year.
The funds will enable Doceree to accelerate product development, augment technologies, scale global expansion, and expand team, the company said in a press release.
Four-year-old Doceree aims to empower pharmaceutical and life-sciences companies and healthcare media agencies with solutions that reach HCPs (healthcare professionals) on their networks to achieve better patient health outcomes.
“The pharma messaging space is evolving at a fast pace and our solutions are aligned to meet the immediate requirements of the life sciences industry. The investment speaks volumes about the value we are creating in the space,” said Harshit Jain MD, founder and global CEO, Doceree.
While Doceree is yet to file its annual financial statement for FY23, it claims to have grown more than 100% in the last year with monthly revenue rising five fold since the Series A round.
In May, Doceree collaborated with Hello Health Group to foray into eight Southeast Asian countries including Vietnam, Indonesia, Malaysia, Cambodia, Myanmar, Singapore, Philippines and Taiwan.
Homegrown private equity fund Creaegis recently closed its maiden fund at about $426 million. The fund is looking to build a portfolio of 12-15 growth stage companies and will back roughly four companies annually. Its portfolio includes Medikabazaar, Zopper, and Kale Logistics among others.